Cargando…

Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer

BACKGROUND: Clinical evidence supports the use of genetic counselling and BRCA1/2 testing for women at risk for hereditary breast and ovarian cancer. Currently, screen-and-treat strategies are not reimbursed in the Brazilian Unified Healthcare System (SUS). The aim of this modelling study was to eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simoes Correa-Galendi, Julia, del Pilar Estevez Diz, Maria, Stock, Stephanie, Müller, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790767/ https://www.ncbi.nlm.nih.gov/pubmed/32537695 http://dx.doi.org/10.1007/s40258-020-00599-0

Ejemplares similares

Data on Utility in Cost–Utility Analyses of Genetic Screen-and-Treat Strategies for Breast and Ovarian Cancer
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2021)

Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2022)

Expectations for the Development of Health Technology Assessment in Brazil
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2021)

Hereditary cancer risk assessment: essential tools for a better approach
por: Gomy, Israel, et al.
Publicado: (2013)

Hereditary cancer risk assessment: insights and perspectives for the Next-Generation Sequencing era
por: Gomy, Israel, et al.
Publicado: (2016)

Early economic modeling of magnetic resonance image-guided high intensity focused ultrasound compared to radiotherapy for pain palliation of bone metastases
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2022)

Perspectives on PARP Inhibitor Combinations for Ovarian Cancer
por: Bonadio, Renata Colombo, et al.
Publicado: (2021)

Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system
por: Arruda, Gustavo Viani, et al.
Publicado: (2022)

Ovarian cancer risk assessment in the era of next-generation sequencing
por: Bonadio, Renata Colombo, et al.
Publicado: (2020)

Cost-effectiveness of hypofractionated versus conventional fractionated radiotherapy for the treatment of men with early glottic cancer: a study in the Brazilian public and private health system
por: Lourenção, Marina, et al.
Publicado: (2023)

Cost-effectiveness of WEB Embolization, Coiling and Stent-assisted Coiling for the Treatment of Unruptured Intracranial Aneurysms
por: Goertz, Lukas, et al.
Publicado: (2023)

Late Isolated Central Nervous System Relapse from Ovarian Serous Adenocarcinoma: A Case Report and Literature Review
por: de Castria, Tiago Biachi, et al.
Publicado: (2014)

The prognostic role of microRNA in epithelial ovarian cancer: a systematic review of literature with an overall survival meta-analysis
por: Ferreira, Patricia, et al.
Publicado: (2020)

Effectiveness of Strategies for Nutritional Therapy for Patients with Type 2 Diabetes and/or Hypertension in Primary Care: A Systematic Review and Meta-Analysis
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2022)

Effectiveness of strategies for nutritional therapy for patients with type 2 diabetes and/or hypertension in primary care: protocol of a systematic review of randomised controlled trials
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2019)

Effectiveness of Medical Treatment of Cushing’s Disease: A Systematic Review and Meta-Analysis
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2021)

Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
por: da Cunha Colombo Bonadio, Renata Rodrigues, et al.
Publicado: (2018)

Zika Virus in a Patient With Cancer: How Much Do We Know?
por: Hepner, Adriana, et al.
Publicado: (2016)

Advanced small-cell ovarian carcinoma, hypercalcemic type: a challenging therapeutic entity
por: Bitton, Rafael Caparica, et al.
Publicado: (2014)

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients
por: Silva, Felipe C, et al.
Publicado: (2014)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
por: Ewald, Ingrid Petroni, et al.
Publicado: (2016)

Hereditary fructose intolerance in Brazilian patients
por: Valadares, Eugênia Ribeiro, et al.
Publicado: (2015)

Health Economic Evaluations of Cancer in Brazil: A Systematic Review
por: Campolina, Alessandro G., et al.
Publicado: (2018)

Methodological issues in economic evaluations of disease prevention and health promotion: an overview of systematic and scoping reviews
por: Seleznova, Yana, et al.
Publicado: (2021)

Brazilian guidelines for the diagnosis and treatment of hereditary angioedema
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2011)

Hereditary angioedema: quality of life in Brazilian patients
por: Gomide, Maria Abadia Consuelo M S, et al.
Publicado: (2013)

Hereditary breast and ovarian cancer
por: Gronwald, Jacek, et al.
Publicado: (2008)

Immune checkpoint inhibitors: here to stay
por: Carvalho, Filomena Marino, et al.
Publicado: (2023)

Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer
por: Gomes, Renan, et al.
Publicado: (2020)

Radiologic screening and surveillance in hereditary cancers
por: Clarke, Jamie E., et al.
Publicado: (2022)

Factors Influencing the Adoption of Magnetic Resonance-Guided High-Intensity Focused Ultrasound for Painful Bone Metastases in Europe, A Group Concept Mapping Study
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2023)

Screening of targeted panel genes in Brazilian patients with primary ovarian insufficiency
por: França, Monica M., et al.
Publicado: (2020)

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
por: Ewald, Ingrid P, et al.
Publicado: (2011)

Pathology of Hereditary Breast and Ovarian Cancer
por: Hodgson, Anjelica, et al.
Publicado: (2020)

Hereditary Angioedema: The Economics of Treatment of an Orphan Disease
por: Lumry, William Raymond
Publicado: (2018)

Effectiveness of non-pharmacological strategies in the management of type 2 diabetes in primary care: a protocol for a systematic review and network meta-analysis
por: Leite, Renata Giacomini Oliveira Ferreira, et al.
Publicado: (2020)

Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy
por: Ghose, Aruni, et al.
Publicado: (2022)

Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States
por: Guzauskas, Gregory F., et al.
Publicado: (2020)

Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
por: Yoshida, Reiko
Publicado: (2020)

Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer
por: Desai, Neelam V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qd00nudhia51omtrr0r8fc1ld0